These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 36918317)
1. Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020. Diaz L; Eiden C; Jouanjus E; Frauger E; Fouilhé N; Djezzar S; Gibaja V; Boucher A; Le Boisselier R; Libert F; Caous AS; Monzon E; Guerlais M; Daveluy A; Fauconneau B; Peyrière H Therapie; 2023; 78(6):647-657. PubMed ID: 36918317 [TBL] [Abstract][Full Text] [Related]
2. Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data. Roussin A; Soeiro T; Fouque C; Jouanjus E; Frauger E; Fouilhé N; Mallaret M; Micallef J; Lapeyre-Mestre M; Br J Clin Pharmacol; 2022 Aug; 88(8):3789-3802. PubMed ID: 35318713 [TBL] [Abstract][Full Text] [Related]
3. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance. Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M; Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345 [No Abstract] [Full Text] [Related]
4. [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health]. Micallef J; Jouanjus É; Mallaret M; Lapeyre Mestre M Therapie; 2019 Dec; 74(6):579-590. PubMed ID: 31694770 [TBL] [Abstract][Full Text] [Related]
6. Health consequences of cocaine use in France: data from the French Addictovigilance Network. Eiden C; Vincent M; Serrand C; Serre A; Richard N; Picot MC; Frauger E; Fouilhé N; Daveluy A; Peyrière H; Fundam Clin Pharmacol; 2021 Apr; 35(2):455-465. PubMed ID: 32854152 [TBL] [Abstract][Full Text] [Related]
7. Mother's little helper turned a foe: Alprazolam use, misuse, and abuse. Cardona-Acosta AM; Meisser N; Vardeleon NI; Steiner H; Bolaños-Guzmán CA Prog Neuropsychopharmacol Biol Psychiatry; 2024 Sep; 136():111137. PubMed ID: 39260815 [TBL] [Abstract][Full Text] [Related]
8. Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network. Frauger E; Pauly V; Pradel V; Rouby F; Arditti J; Thirion X; Lapeyre Mestre M; Micallef J Fundam Clin Pharmacol; 2011 Oct; 25(5):633-41. PubMed ID: 21077937 [TBL] [Abstract][Full Text] [Related]
9. Addictovigilance contribution during COVID-19 epidemic and lockdown in France. Lapeyre-Mestre M; Boucher A; Daveluy A; Gibaja V; Jouanjus E; Mallaret M; Peyrière H; Micallef J; Therapie; 2020; 75(4):343-354. PubMed ID: 32660776 [TBL] [Abstract][Full Text] [Related]
10. [Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy (France)]. Barberot P; Gibaja V; Benkhedda C; Dobre D; Tournebize J; Kahn JP Therapie; 2019 Jun; 74(3):389-397. PubMed ID: 30392700 [TBL] [Abstract][Full Text] [Related]
11. [Surveillance system on drug abuse: Interest of the French national OPPIDUM program of French addictovigilance network]. Frauger E; Pochard L; Boucherie Q; Giocanti A; Chevallier C; Daveluy A; Gibaja V; Caous AS; Eiden C; Authier N; Le Boisselier R; Guerlais M; Jouanjus É; Lepelley M; Pizzoglio V; Pain S; Richard N; Micallef J; Therapie; 2017 Sep; 72(4):491-501. PubMed ID: 28343650 [TBL] [Abstract][Full Text] [Related]
12. A Review of Alprazolam Use, Misuse, and Withdrawal. Ait-Daoud N; Hamby AS; Sharma S; Blevins D J Addict Med; 2018; 12(1):4-10. PubMed ID: 28777203 [TBL] [Abstract][Full Text] [Related]
13. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014. Calcaterra SL; Severtson SG; Bau GE; Margolin ZR; Bucher-Bartelson B; Green JL; Dart RC Clin Toxicol (Phila); 2018 Nov; 56(11):1107-1114. PubMed ID: 29609498 [TBL] [Abstract][Full Text] [Related]
15. Sex/gender differences in spontaneous reports to a French Addictovigilance centre. Peyriére H; Dampierre A; Vallo R; Lestienne M; Eiden C; Donnadieu H Arch Womens Ment Health; 2024 Jul; ():. PubMed ID: 38980402 [TBL] [Abstract][Full Text] [Related]
16. Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam. Albeck JH J Clin Psychiatry; 1987 Oct; 48 Suppl():43-9. PubMed ID: 2889723 [TBL] [Abstract][Full Text] [Related]
18. French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change. Aquizerate A; Laforgue EJ; Istvan M; Rousselet M; Gerardin M; Jouanjus E; Libert F; ; Guerlais M; Victorri-Vigneau C Eur J Public Health; 2023 Apr; 33(2):169-175. PubMed ID: 36749030 [TBL] [Abstract][Full Text] [Related]
19. Signal identification in addictovigilance: the functioning of the French system. Jouanjus E; Gibaja V; Kahn JP; Haramburu F; Daveluy A Therapie; 2015; 70(2):113-31. PubMed ID: 25858567 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of alprazolam-related deaths compiled by a centralized state medical examiner. Shah NA; Abate MA; Smith MJ; Kaplan JA; Kraner JC; Clay DJ Am J Addict; 2012 Nov; 21 Suppl 1():S27-34. PubMed ID: 23786507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]